These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10575734)

  • 1. Synthesis and X-ray crystal structure of the calcium channel antagonist: dimethyl 1,4-dihydro-2,6-dimethyl-4-[4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl]- 3,5-pyridine dicarboxylate.
    Tunçbilek M; Ozbey S; Kendi E; Yildirim E; Erol K; Ertan R
    Farmaco; 1999 Oct; 54(10):660-5. PubMed ID: 10575734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
    Sakoda R; Kamikawaji Y; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
    Sakoda R; Matsumoto H; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2377-81. PubMed ID: 1446358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioactivity and solid-state structure of two 4-isoxazolyldihydropyridines related to the 4-aryldihydropyridine calcium-channel blockers.
    McKenna JI; Schlicksupp L; Natale NR; Willett RD; Maryanoff BE; Flaim SF
    J Med Chem; 1988 Feb; 31(2):473-6. PubMed ID: 3339618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
    Anana RD; Ng H; Howlett SE; Knaus EE
    Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
    Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
    Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of some 4-[3' or 4'-(4H- 4-oxo-1-benzopyran-2-yl)phenyl]-1,4-dihydropyridine derivatives as potential calcium channel antagonists.
    Tunçbilek M; Ertan R
    Pharmazie; 1999 Apr; 54(4):255-9. PubMed ID: 10234737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Methyl 5-isopropyl 2-methoxyiminomethyl-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
    Vrábel V; Lehotay J; Oktavec D; Marchalín S
    Acta Crystallogr C; 2001 Sep; 57(Pt 9):1073-4. PubMed ID: 11588375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microwave-assisted synthesis and spasmolytic activity of 4-indolylhexahydroquinoline derivatives.
    El-Khouly A; Gündüz MG; Cengelli C; Simşek R; Erol K; Safak C; Yıldırım SO; Butcher RJ
    Drug Res (Stuttg); 2013 Nov; 63(11):579-85. PubMed ID: 23804251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, spectroscopic, DFT, and molecular docking studies on 1,4-dihydropyridine derivative compounds: a combined experimental and theoretical study.
    Karthick R; Velraj G; Pachamuthu MP; Karthikeyan S
    J Mol Model; 2021 Dec; 28(1):5. PubMed ID: 34889990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators.
    Rovnyak GC; Kimball SD; Beyer B; Cucinotta G; DiMarco JD; Gougoutas J; Hedberg A; Malley M; McCarthy JP; Zhang R
    J Med Chem; 1995 Jan; 38(1):119-29. PubMed ID: 7837222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[4-(1-methoxycarbonyl-1,4-dihydropyridyl)]-3 ,5- pyridinedicarboxylates.
    Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
    Arch Pharm (Weinheim); 1999 Nov; 332(11):385-8. PubMed ID: 10605379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two 1,4-dihydropyridine derivatives with potential calcium-channel antagonist activity.
    Linden A; Safak C; Simşek R; Gündüz MG
    Acta Crystallogr C; 2011 Feb; 67(Pt 2):o80-4. PubMed ID: 21285508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine.
    Alajarin R; Vaquero JJ; Alvarez-Builla J; Pastor M; Sunkel C; Fau de Casa-Juana M; Priego J; Statkow PR; Sanz-Aparicio J; Fonseca I
    J Med Chem; 1995 Jul; 38(15):2830-41. PubMed ID: 7636844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
    Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
    Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor model for the molecular basis of tissue selectivity of 1, 4-dihydropyridine calcium channel drugs.
    Langs DA; Strong PD; Triggle DJ
    J Comput Aided Mol Des; 1990 Sep; 4(3):215-30. PubMed ID: 2177783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
    Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
    Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of 2,6-dimethyl-4-disubstituted phenyl-1,4-dihydropyridine-3,5-dicarboxylates as antimyocardial ischemic agents].
    Yan ZM; Dong YM
    Yao Xue Xue Bao; 1991; 26(9):661-6. PubMed ID: 1821085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.